Target intelligence / Profile preview

RNA, 5S ribosomal pseudogene 489 (RNA5SP489)

Target
RNA5SP489
Molecular classification
Pseudogene, processed pseudogene, rRNA pseudogene
01

Overview

RNA, 5S ribosomal pseudogene 489 (RNA5SP489) is a **processed pseudogene** derived from the parent 5S rRNA gene family. Unlike functional 5S rRNA, which is a critical component of the large ribosomal subunit required for protein synthesis in all organisms except fungal and animal mitochondria[1], RNA5SP489 has lost its ability to function due to accumulated mutations resulting from retrotransposition. Processed pseudogenes typically lack functional promoters and introns, are located away from their parental genes, and are not transcribed into functional RNA[2][4]. RNA5SP489 is classified as an rRNA pseudogene and is catalogued in gene databases as a non-protein-coding locus with no known function, disease association, or role as a therapeutic target[3][2]. **Summary of Key Points:** - RNA5SP489 is a **processed pseudogene** (not a receptor or drug target). - It is not **therapeutically actionable**. - There is **no evidence of biological or pathological function**, and **no drugs** interact with it. - Information about RNA5SP489 is limited to its annotation as a non-functional rRNA pseudogene. **Note:** This entry is likely **incorrect as a drug target**, since pseudogenes in general—and RNA5SP489 specifically—do not function as receptors, enzymes, or other molecular targets for therapeutics[3][2][4].

Other names
RN5S489RNA, 5S ribosomal 489RNA5SP489
02

Mechanism of action

Not applicable; there are no drugs or mechanisms of action reported for RNA5SP489.

03

Biological functions

Pseudogenes generally lack biological function due to mutations preventing normal transcription or translation; some pseudogenes may have regulatory functions but there is no evidence for functional activity of RNA5SP489.
04

Disease associations

There is no disease association reported for RNA5SP489; some pseudogenes are linked to disease states (e.g., cancer), but no direct evidence exists for RNA5SP489.
05

Safety considerations

None; pseudogenes do not present therapeutic safety concerns unless expressed aberrantly, which is not reported for RNA5SP489.
06

Interacting drugs

None reported; pseudogenes such as RNA5SP489 do not encode proteins or functional RNAs that act as drug targets.
07

Biomarkers

None reported; RNA5SP489 is not used as a biomarker.

Beyond the preview

Go deeper on RNA, 5S ribosomal pseudogene 489 (RNA5SP489).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, 5S ribosomal pseudogene 489 (RNA5SP489).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call